Dr. Angelika Starzer (@StarzerAngelika) gave an excellent overview of novel HER2-targeted agents in #BreastCancer at our recent HER2+ Working Group meeting. She discussed the mechanism of action, preclinical highlights, clinical data to date, and ongoing trials - many of these are being done at @DanaFarber!
Angelika Starzer, MD (@StarzerAngelika) attended the Max Kade Foundation scholarship ceremony in Vienna, which was presided by Austria’s Ministers of Education and Research. Congratulations, Angelika!
📸Photo copyright: ÖAW/Daniel Hinterramskogler
Meet Angelika Starzer (@StarzerAngelika) she has recently joined as an Advanced Research Fellow in the Breast Oncology Center @DanaFarber. She obtained her medical degree from the Medical University of Vienna, Austria (@MedUni_Wien) and is currently completing her PhD, which is focused on biomarkers predicting #Immunotherapy response in solid tumors. Her research centers on #BreastCancer, with a particular emphasis on #ADCs and #BrainMetastases. She will work closely with Drs. Nancy Lin (@nlinmd) and Sarah Sammons (@drsarahsam).
👉 Stay up to date with the latest evidence-based recommendations from the #ESMOGuidelines for the treatment of metastatic #breastcancer to optimise patient outcomes.
Join this live discussion and submit your questions
🔗 https://t.co/hLznsT4sKX